1) LYVE-1
淋巴管内皮透明质酸受体-1
1.
Methods: Double immunohistochemical staining for LYVE-1/CD34 for 40 cases of pulmonary squamocellular carcinoma and 10 cases of pulmonary inflammatory pseudotumor were performed to distinguish lymphoducts and blood vessels, and to observe the lymphatic vessel endothelial HA receptor-1(LYVE-1) manifestation.
用LYVE-1/CD34免疫组化双染色法区分淋巴管和血管并观察淋巴管内皮透明质酸受体-1(LYVE-1)蛋白表达的情况。
2.
Methods:In18cases of pulmonary squamous cell carcinoma having mediastinal lymph node metastasis,22cases of pulmonary squa-mous cell carcinoma having no mediastinal lymph node metastasis and10cases of pulmonary poroma,double immunohistochemical staining for LYVE-1/CD34was performed to distinguish lymphoducts from blood vessels,and observe.
用LYVE-1/CD34免疫组化双染色法区分淋巴管和血管并观察淋巴管内皮透明质酸受体-1(LYVE-1)蛋白表达的情况,并与手术纵隔淋巴结清扫病理结果相比较。
2) Lymphatic vessel endothelial hyaluronan receptor-1
淋巴管内皮透明质酸受体-1
1.
Results: The positive expression of lymphatic vessel endothelial hyaluronan receptor-1(LYVE-1) was found in the lymphatic vessels,while the negative expressions of β-cate.
通过免疫组织化学方法,用淋巴管内皮透明质酸受体-1(LYVE-1)标记定位,观察胃癌淋巴管E钙黏蛋白和β连环素的表达。
3) Lymphatic vessel endothelial hyaluronan receptor-1
淋巴管内皮细胞透明质酸受体1
4) LYVE-1
淋巴管内皮细胞透明质酸受体-1
1.
Objective To investigate the distribution of intrarenal lymphatic vessels in developing rat using the lymphatic marker LYVE-1.
目的探讨淋巴管内皮细胞透明质酸受体-1染色阳性(LYVE-1+)淋巴管在大鼠肾内的分布。
5) lymphatic vessel endothelial hyaluronan receptor
淋巴管内皮特异性透明质酸受体
1.
Objective To obtain a soluble and stable recombinant human lymphatic vessel endothelial hyaluronan receptor(LYVE-1) whose antigen is identical to that of human for the study of lymphangiogenesis and clinical tumor immuno-diagnosis.
目的获得可溶、稳定、与人淋巴管内皮特异性透明质酸受体(LYVE-1)具备相同抗原性的重组人LYVE-1,为进一步研究LYVE-1在淋巴管形成中的作用及临床肿瘤免疫学诊断打下基础、提供材料。
6) Flt4
淋巴管内皮细胞表面受体
补充资料：内皮素受体
内皮素受体
目前对ETR的调节机制了解极少，可能雌激素促其形成，而孕激素有抑制作用。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条